Treatment for advanced hepatitis C doesn't work, researchers find
Wednesday, December 3, 2008 - 18:49
in Health & Medicine
An NIH funded multi-center clinical trial found no benefit from "maintenance therapy," low-dose peginterferon used for hepatitis C patients who have not responded to an initial round of treatment. In addition, the study showed a surprising health decline in patients with liver disease over the course of four years.